Role of image-guided therapies in hepatocellular carcinoma


  • Arii S, Teramoto K, Kawamura T, Okamoto H, Kaido T, Mori    A, et al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg 2001;8:397-403.
  • Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001; 35:421-430
  • Ikeda M, Okada S, Ueno H, Okusaka T, Kuryama H. Radio-   frequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol 2001; 31:322-326.
  • Lencioni R, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutanous ethanol injection. Radiology 2003;228:235-240.
  • Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli    G, Vettori C. Long term results of single session PEI in patients with large hepatocellular carcinoma. Cancer 1998; 83:48-57.
  • Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661.
  • Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
  • Livraghi T, Meloni F, Corso R, Rampoldi A. Comparison   between RF ablation and TACE in the treatment of multifocal hepatocellular carcinoma: preliminary experience. Radiology 2000; 217(P):787.
  • Livraghi T, Solbiati L, Meloni F, Gazelle GS, Halpren EF, Goldberg SN. Percutaneous radio-frequency ablation: complications encountered in a multicenter study of the treatment of focal liver tumors. Radiology 2003; 226:441-451.
  • Livraghi T, Meloni F, Morabito A, Vettori C. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liv Transpl 2004; 10: S98-S106
  • Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19:329-338.
  • Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359:1734-1738.
  • Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171.
  • Matsui O, Kadoya M, Yoshikawa J, Gabata T, Takashima T, Demachi H. Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 1994;33:S 84-S 88.
  • Nakashima O, Kojiro M. Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastases? A viewpoint in terms of pathology. J Hepatobiliary Pancreat Surg 2001;8:404-409.
  • Ryu M, Shimamura Y, Kinoshita T, Konishi M, Kawano N, Iwasaki M, et al. Therapeutic results of resection, transcatheter arterial embolization and ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol
  • 1997;27:251-257.